Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Mllt3 | Rat | 1,2-dichloroethane | increases expression | ISO | Mllt3 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of MLLT3 mRNA | CTD | PMID:28189721|PMID:28960355 | Mllt3 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of MLLT3 mRNA | CTD | PMID:22206623 | Mllt3 | Rat | 1,3-dinitrobenzene | increases expression | EXP | | 6480464 | 3-dinitrobenzene results in increased expression of MLLT3 mRNA | CTD | PMID:21983209 | Mllt3 | Rat | 17beta-estradiol | affects expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Estradiol affects the expression of MLLT3 mRNA | CTD | PMID:22574217 | Mllt3 | Rat | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of MLLT3 mRNA | CTD | PMID:26496021 | Mllt3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Mllt3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MLLT3 mRNA | CTD | PMID:19933214 | Mllt3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of MLLT3 mRNA | CTD | PMID:34747641 | Mllt3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MLLT3 mRNA | CTD | PMID:22574217 | Mllt3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Mllt3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of MLLT3 mRNA | CTD | PMID:21570461 | Mllt3 | Rat | 2-methoxyethanol | increases expression | EXP | | 6480464 | methyl cellosolve results in increased expression of MLLT3 mRNA | CTD | PMID:21061450 | Mllt3 | Rat | 2-palmitoylglycerol | increases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | 2-palmitoylglycerol results in increased expression of MLLT3 mRNA | CTD | PMID:37199045 | Mllt3 | Rat | 3-chloropropane-1,2-diol | increases expression | EXP | | 6480464 | alpha-Chlorohydrin results in increased expression of MLLT3 mRNA | CTD | PMID:28522335 | Mllt3 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of MLLT3 mRNA | CTD | PMID:39298647 | Mllt3 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of MLLT3 mRNA | CTD | PMID:28973697 | Mllt3 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of MLLT3 mRNA | CTD | PMID:24780913|PMID:30047161 | Mllt3 | Rat | aflatoxin B1 | increases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of MLLT3 mRNA | CTD | PMID:27153756 | Mllt3 | Rat | Aflatoxin B2 alpha | decreases methylation | ISO | MLLT3 (Homo sapiens) | 6480464 | aflatoxin B2 results in decreased methylation of MLLT3 intron | CTD | PMID:30157460 | Mllt3 | Rat | all-trans-retinoic acid | decreases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of MLLT3 mRNA | CTD | PMID:23724009 | Mllt3 | Rat | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of MLLT3 mRNA | CTD | PMID:30047161 | Mllt3 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of MLLT3 mRNA | CTD | PMID:16483693 | Mllt3 | Rat | antirheumatic drug | increases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of MLLT3 mRNA | CTD | PMID:24449571 | Mllt3 | Rat | aristolochic acid A | decreases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of MLLT3 mRNA | CTD | PMID:33212167 | Mllt3 | Rat | atrazine | increases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Atrazine results in increased expression of MLLT3 mRNA | CTD | PMID:22378314 | Mllt3 | Rat | benzo[a]pyrene | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of MLLT3 mRNA | CTD | PMID:21715664 | Mllt3 | Rat | benzo[a]pyrene | affects methylation | ISO | MLLT3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MLLT3 intron | CTD | PMID:30157460 | Mllt3 | Rat | benzo[a]pyrene | decreases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of MLLT3 mRNA | CTD | PMID:20106945|PMID:21632981 | Mllt3 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MLLT3 mRNA | CTD | PMID:19150397 | Mllt3 | Rat | benzo[e]pyrene | affects methylation | ISO | MLLT3 (Homo sapiens) | 6480464 | benzo(e)pyrene affects the methylation of MLLT3 intron | CTD | PMID:30157460 | Mllt3 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of MLLT3 mRNA | CTD | PMID:34319233 | Mllt3 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of MLLT3 mRNA | CTD | PMID:26496021 | Mllt3 | Rat | bisphenol A | decreases methylation | ISO | MLLT3 (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of MLLT3 gene | CTD | PMID:31601247 | Mllt3 | Rat | bisphenol A | increases expression | ISO | Mllt3 (Mus musculus) | 6480464 | bisphenol A results in increased expression of MLLT3 mRNA | CTD | PMID:34585602 | Mllt3 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of MLLT3 mRNA | CTD | PMID:30816183 | Mllt3 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of MLLT3 gene | CTD | PMID:28505145 | Mllt3 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of MLLT3 mRNA | CTD | PMID:25181051 | Mllt3 | Rat | Butylbenzyl phthalate | increases methylation | ISO | Mllt3 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of MLLT3 intron | CTD | PMID:28392331 | Mllt3 | Rat | cadmium atom | multiple interactions | ISO | Mllt3 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MLLT3 more ... | CTD | PMID:28111341|PMID:37236586 | Mllt3 | Rat | cadmium dichloride | multiple interactions | ISO | Mllt3 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MLLT3 more ... | CTD | PMID:28111341|PMID:37236586 | Mllt3 | Rat | cadmium sulfate | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | cadmium sulfate results in decreased expression of MLLT3 mRNA | CTD | PMID:19274763 | Mllt3 | Rat | carbamazepine | affects expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of MLLT3 mRNA | CTD | PMID:25979313 | Mllt3 | Rat | carbon nanotube | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | Nanotubes, Carbon results in decreased expression of MLLT3 mRNA | CTD | PMID:25554681 | Mllt3 | Rat | chloroprene | increases expression | EXP | | 6480464 | Chloroprene results in increased expression of MLLT3 mRNA | CTD | PMID:23125180 | Mllt3 | Rat | chlorpyrifos | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of MLLT3 mRNA | CTD | PMID:37019170 | Mllt3 | Rat | choline | multiple interactions | ISO | Mllt3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Mllt3 | Rat | clotrimazole | increases expression | EXP | | 6480464 | Clotrimazole results in increased expression of MLLT3 mRNA | CTD | PMID:30047161 | Mllt3 | Rat | cyclosporin A | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of MLLT3 mRNA | CTD | PMID:19770486 | Mllt3 | Rat | cyclosporin A | decreases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of MLLT3 mRNA | CTD | PMID:20106945|PMID:25562108|PMID:27989131 | Mllt3 | Rat | dicrotophos | decreases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of MLLT3 mRNA | CTD | PMID:28302478 | Mllt3 | Rat | dioxygen | multiple interactions | ISO | Mllt3 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of MLLT3 mRNA | CTD | PMID:30529165 | Mllt3 | Rat | dorsomorphin | multiple interactions | ISO | MLLT3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Mllt3 | Rat | doxorubicin | decreases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of MLLT3 mRNA | CTD | PMID:16404146 | Mllt3 | Rat | doxorubicin | increases expression | ISO | Mllt3 (Mus musculus) | 6480464 | Doxorubicin results in increased expression of MLLT3 mRNA | CTD | PMID:39631538 | Mllt3 | Rat | epoxiconazole | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of MLLT3 mRNA | CTD | PMID:35436446 | Mllt3 | Rat | flavonoids | decreases expression | EXP | | 6480464 | Flavonoids results in decreased expression of MLLT3 mRNA | CTD | PMID:18035473 | Mllt3 | Rat | folic acid | multiple interactions | ISO | Mllt3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Mllt3 | Rat | folic acid | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of MLLT3 mRNA | CTD | PMID:25629700 | Mllt3 | Rat | FR900359 | decreases phosphorylation | ISO | MLLT3 (Homo sapiens) | 6480464 | FR900359 results in decreased phosphorylation of MLLT3 protein | CTD | PMID:37730182 | Mllt3 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of MLLT3 mRNA | CTD | PMID:33387578 | Mllt3 | Rat | GSK-J4 | increases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | GSK-J4 results in increased expression of MLLT3 mRNA | CTD | PMID:29301935 | Mllt3 | Rat | inulin | multiple interactions | ISO | Mllt3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MLLT3 mRNA | CTD | PMID:36331819 | Mllt3 | Rat | ketamine | decreases expression | EXP | | 6480464 | Ketamine results in decreased expression of MLLT3 mRNA | CTD | PMID:20080153 | Mllt3 | Rat | L-methionine | multiple interactions | ISO | Mllt3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Mllt3 | Rat | lead diacetate | increases expression | ISO | Mllt3 (Mus musculus) | 6480464 | lead acetate results in increased expression of MLLT3 mRNA | CTD | PMID:21829687 | Mllt3 | Rat | lead diacetate | multiple interactions | ISO | MLLT3 (Homo sapiens) | 6480464 | [lead acetate co-treated with zinc protoporphyrin] results in increased expression of MLLT3 mRNA | CTD | PMID:22839698 | Mllt3 | Rat | leflunomide | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | leflunomide results in decreased expression of MLLT3 mRNA | CTD | PMID:19751817 | Mllt3 | Rat | melphalan | decreases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Melphalan results in decreased expression of MLLT3 mRNA | CTD | PMID:22363485 | Mllt3 | Rat | methapyrilene | affects methylation | ISO | MLLT3 (Homo sapiens) | 6480464 | Methapyrilene affects the methylation of MLLT3 intron | CTD | PMID:30157460 | Mllt3 | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of MLLT3 mRNA | CTD | PMID:30047161 | Mllt3 | Rat | methyl methanesulfonate | decreases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of MLLT3 mRNA | CTD | PMID:23649840 | Mllt3 | Rat | methylmercury chloride | decreases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of MLLT3 mRNA | CTD | PMID:28001369 | Mllt3 | Rat | N-nitrosodiethylamine | increases expression | ISO | Mllt3 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of MLLT3 mRNA | CTD | PMID:24535843 | Mllt3 | Rat | nickel sulfate | decreases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of MLLT3 mRNA | CTD | PMID:22714537 | Mllt3 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of MLLT3 mRNA | CTD | PMID:25729387 | Mllt3 | Rat | paracetamol | affects expression | ISO | Mllt3 (Mus musculus) | 6480464 | Acetaminophen affects the expression of MLLT3 mRNA | CTD | PMID:17562736 | Mllt3 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of MLLT3 mRNA | CTD | PMID:33387578 | Mllt3 | Rat | paracetamol | affects expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Acetaminophen affects the expression of MLLT3 mRNA | CTD | PMID:25458485 | Mllt3 | Rat | paracetamol | decreases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of MLLT3 mRNA | CTD | PMID:26690555 | Mllt3 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Mllt3 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of MLLT3 mRNA | CTD | PMID:37995155 | Mllt3 | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in increased expression of MLLT3 mRNA | CTD | PMID:25812627 | Mllt3 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Mllt3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of MLLT3 mRNA | CTD | PMID:36331819 | Mllt3 | Rat | perfluorooctanoic acid | increases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of MLLT3 mRNA | CTD | PMID:25812627 | Mllt3 | Rat | propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of MLLT3 mRNA | CTD | PMID:30047161 | Mllt3 | Rat | quercetin | decreases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of MLLT3 mRNA | CTD | PMID:21632981 | Mllt3 | Rat | SB 431542 | multiple interactions | ISO | MLLT3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Mllt3 | Rat | silver atom | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | Silver results in decreased expression of MLLT3 mRNA | CTD | PMID:27131904 | Mllt3 | Rat | silver(0) | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | Silver results in decreased expression of MLLT3 mRNA | CTD | PMID:27131904 | Mllt3 | Rat | sodium arsenite | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of MLLT3 mRNA | CTD | PMID:35961411 | Mllt3 | Rat | sodium arsenite | multiple interactions | ISO | Mllt3 (Mus musculus) | 6480464 | sodium arsenite inhibits the reaction [GATA2 protein binds to MLLT3 promoter] | CTD | PMID:35961411 | Mllt3 | Rat | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of MLLT3 mRNA | CTD | PMID:30047161 | Mllt3 | Rat | sunitinib | decreases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of MLLT3 mRNA | CTD | PMID:31533062 | Mllt3 | Rat | testosterone | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | Testosterone results in decreased expression of MLLT3 mRNA | CTD | PMID:20403060 | Mllt3 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of MLLT3 mRNA | CTD | PMID:34492290 | Mllt3 | Rat | titanium dioxide | decreases methylation | ISO | Mllt3 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of MLLT3 gene | CTD | PMID:35295148 | Mllt3 | Rat | titanium dioxide | increases expression | ISO | Mllt3 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of MLLT3 mRNA | CTD | PMID:35295148 | Mllt3 | Rat | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of MLLT3 mRNA | CTD | PMID:25729387 | Mllt3 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of MLLT3 mRNA | CTD | PMID:25729387 | Mllt3 | Rat | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of MLLT3 gene | CTD | PMID:27618143 | Mllt3 | Rat | trichostatin A | increases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of MLLT3 mRNA | CTD | PMID:24935251 | Mllt3 | Rat | trichostatin A | affects expression | ISO | MLLT3 (Homo sapiens) | 6480464 | trichostatin A affects the expression of MLLT3 mRNA | CTD | PMID:28542535 | Mllt3 | Rat | triphenyl phosphate | increases expression | EXP | | 6480464 | triphenyl phosphate results in increased expression of MLLT3 mRNA | CTD | PMID:30589522 | Mllt3 | Rat | triphenyl phosphate | affects expression | ISO | MLLT3 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of MLLT3 mRNA | CTD | PMID:37042841 | Mllt3 | Rat | triptonide | decreases expression | ISO | Mllt3 (Mus musculus) | 6480464 | triptonide results in decreased expression of MLLT3 mRNA | CTD | PMID:33045310 | Mllt3 | Rat | urethane | increases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Urethane results in increased expression of MLLT3 mRNA | CTD | PMID:28818685 | Mllt3 | Rat | valproic acid | affects expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of MLLT3 mRNA | CTD | PMID:25979313|PMID:26072468 | Mllt3 | Rat | valproic acid | multiple interactions | ISO | MLLT3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Mllt3 | Rat | valproic acid | increases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MLLT3 mRNA | CTD | PMID:19101580|PMID:23179753|PMID:24935251|PMID:26272509|PMID:28001369 | Mllt3 | Rat | valproic acid | affects expression | ISO | Mllt3 (Mus musculus) | 6480464 | Valproic Acid affects the expression of MLLT3 mRNA | CTD | PMID:17292431|PMID:26072468 | Mllt3 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of MLLT3 mRNA | CTD | PMID:20566332 | Mllt3 | Rat | vincristine | increases expression | ISO | MLLT3 (Homo sapiens) | 6480464 | Vincristine results in increased expression of MLLT3 mRNA | CTD | PMID:23649840 | Mllt3 | Rat | zinc protoporphyrin | multiple interactions | ISO | MLLT3 (Homo sapiens) | 6480464 | [lead acetate co-treated with zinc protoporphyrin] results in increased expression of MLLT3 mRNA | CTD | PMID:22839698 | |






















